- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06228157
Efficacy of Stellate Ganglion Block in Children With Autistic Disorder (SGB-gudu)
A Randomized Controlled Trial To Explore the Efficacy of Stellate Ganglion Block in Children With Autistic Disorder
The goal of this clinical trial is to explore efficacy of stellate ganglion block Children with Autistic Disorder. The main question it aims to answer is:
Can stellate ganglion block improve the Autistic Disorder in children? Children with Autistic Disorder will be divided into the control group and experimental group evenly. All the patients were provided with routine therapy, while the patients in the experimental group were given stellate ganglion block. The Childhood Autism Rating Scale of the two groups of patients before and after treatment are evaluated.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Autistic Disorder in children is becoming increasingly more. The goal of this clinical trial is to explore efficacy of stellate ganglion block Children with Autistic Disorder. The main question it aims to answer is:
Can stellate ganglion block improve the Autistic Disorder in children? Children with Autistic Disorder will be divided into the control group and experimental group evenly. All the patients were provided with routine therapy, while the patients in the experimental group were given stellate ganglion block. The Childhood Autism Rating Scale of the two groups of patients before and after treatment are evaluated.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450000
- Zheng Da yi Yuan Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosed as Autistic Disorder.
- Aged between 6 years old and 12 years old.
- No contraindications to stellate ganglion block.
Exclusion Criteria:
- Other significant physical or neurodevelopmental disorders.
- Other significant medical conditions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: the experimental group
The study lasts 20d for each patient. During the treatment, All the participants are provided with the routine rehabilitation therapy. Based on the invention above, the patients in the experimental group were provided with stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g) |
The study lasts 20d for each patient.
During the treatment, All the participants are provided with the routine therapy, which included routine rehabilitation, cognitive training.
Based on the invention above, the patients in the experimental group were provided with Stellate ganglion block , using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g).
The percutaneous approach via the paratracheal route was used for Stellate ganglion block.
The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck.
Then, routine disinfection of the neck skin was performed.
The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
|
Active Comparator: the control group
The study lasts 20d for each patient.
During the treatment, All the participants are provided with the routine rehabilitation therapy.
|
The study lasts 20d for each patient.
During the treatment, All the participants are provided with the routine therapy, which included routine rehabilitation, cognitive training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Childhood Autism Rating Scale
Time Frame: day 1 and day 20
|
In the Childhood Autism Rating Scale, the rater observes the behavior of the child in specific situations and assigns scores based on a series of descriptive items.
Each item is scored on a range of 0 to 4, with 0 indicating no abnormality and 4 indicating severe abnormality.
The rater also considers the overall impression and severity of the child, resulting in a total score.
The total score falls between 15 and 60, with higher scores indicating a higher level of autism severity.
|
day 1 and day 20
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Children's Communication Checklist
Time Frame: day 1 and day 20
|
This checklist was to assess language abilities in children aged 2-16.
It consists of 70 items divided into eight subscales, including vocabulary, grammar, comprehension, expression, communication, regulation, fluency, and nonverbal communication.
Scores range from 0-280, with higher scores indicating better language ability.
|
day 1 and day 20
|
Social Interaction Assessment Scale
Time Frame: day 1 and day 20
|
This scale was developed by American psychiatrist Eric Schopler and colleagues to assess social interaction and behavior in children with autism and related disorders.
It consists of 29 items divided into three subscales, including social interaction, maladaptive behavior, and language/communication.
Scores range from 0-87, with higher scores indicating better social interaction and behavior.
|
day 1 and day 20
|
Children's Depression Inventory
Time Frame: day 1 and day 20
|
This inventory was developed by American psychologist Maria Kovacs to assess depression in children aged 7-17.
It consists of 27 items covering aspects such as sad mood, self-evaluation, life satisfaction, insomnia, and early morning awakening.
Scores range from 0-54, with higher scores indicating greater severity of depression.
|
day 1 and day 20
|
Childhood Anxiety Sensitivity Index
Time Frame: day 1 and day 20
|
This index was developed by Australian psychologist Ronald Rapee and colleagues to assess anxiety sensitivity in children aged 8-15.
It consists of 18 items covering physical sensations, cognition, and behavior.
Scores range from 0-54, with higher scores indicating greater anxiety sensitivity.
|
day 1 and day 20
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Nieto Luis, Master, Site Coordinator of United Medical Group located in Miami
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-KY-0119-018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autistic Disorder
-
Mahidol UniversityCompleted
-
Hadassah Medical OrganizationTerminated
-
Fundatia Bio-ForumSpitalul AngiomedicaCompletedAutistic Spectrum DisorderRomania
-
University of JazanCompletedAutistic Spectrum DisorderSaudi Arabia
-
Assistance Publique - Hôpitaux de ParisHopital Universitaire Robert-Debre; Henri Mondor University Hospital; Fondation... and other collaboratorsCompleted
-
Sutter Medical FoundationCompleted
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hospital Parc Taulí, SabadellUnknownSexual Behavior | Adolescent Development | Autistic Disorders Spectrum | Sexual InadequacySpain
-
Université de Reims Champagne-ArdenneNot yet recruitingImpact of Mixed Reality Training on Motor Skills in Children With Autistic Spectrum Disorder (RAMAu)Autistic Spectrum Disorder
-
Addis Ababa UniversityCompletedAutistic Spectrum DisorderEthiopia
Clinical Trials on Routine therapy
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted
-
University of LahoreRecruitingMild Traumatic Brain InjuryPakistan
-
Riphah International UniversityRecruitingCerebral PalsyPakistan
-
University of LahoreRecruitingChronic Hemorrhagic StrokePakistan
-
University of LahoreRecruitingHemiplegic Cerebral PalsyPakistan
-
Riphah International UniversityCompleted
-
University of LahoreRecruiting
-
University of LahoreRiphah International UniversityCompleted
-
University of LahoreRecruiting